Boston Consulting Group and NIBRT announce the Biopharma 4.0 Alliance

Boston Consulting Group (BCG) and National Institute for Bioprocessing Research and Training (NIBRT) are delighted to formally announce the creation of the Biopharma 4.0 (B4.0) Alliance for Digital Innovation in Operations.

The Alliance, the first of its kind globally, is a unique collaboration between leading players in the biopharma industry such as Takeda, selected innovative technology providers and industry experts from BCG and NIBRT.
The team has recently completed the B4.0 design blueprint, which lays out in detail the top 95 industry 4.0 use cases as applied to biopharma manufacturing. The blueprint outlines how biopharma companies can use cutting-edge technologies such as robotics, artificial intelligence and augmented reality to revolutionise manufacturing operations.
The Alliance, formed in September 2018, will now move into the next phase, involving the build out of a physical “digital demonstrator” based in NIBRT’s Dublin facility.

The demonstrator will cover the latest I4.0 technologies in manufacturing, quality control, quality assurance and cross plant operations. These technologies will be seamlessly integrated with core operating processes to enable proof-of-concept studies on new innovations and new ways of working. Visitors to the centre will be able to experience and learn about these technologies, as well as pilot specific use-cases and co-develop I4.0 solutions with NIBRT & BCG.

You can read the full press release here.